Crypto Asset Statement - Injective

Coinsquare Capital Markets Inc. (“Coinsquare”) is offering crypto contracts to purchase and sell Injective in reliance on a prospectus exemption granted by the Canadian Securities Administrators (CSA) in the exemptive relief decision dated October 12, 2022. The statutory rights of action for damages and the right of rescission in section 130.1 of the Securities Act (Ontario) and similar legislation in the other CSA jurisdictions do not apply in respect of a misrepresentation in this statement to the extent that a crypto contract is distributed under the above-noted prospectus relief.

No securities regulatory authority in Canada or any other jurisdiction has expressed an opinion about any of the crypto assets (or crypto contracts) that are available through Coinsquare’s platform, including an opinion that the crypto assets are not themselves securities and/or derivatives.

Coinsquare has compiled the information contained in this Crypto Asset Statement to the best of its ability based on publicly available information. 

Injective is the governance token of the Injective blockchain, a layer-1 network which markets itself as the blockchain built for finance. Injective boasts unique features such as an on-chain order book that supports spot, futures, and derivatives trading, that aim to attract those who would build financial dApps.1 Injective was built using the Cosmos SDK, and consequently uses the Tendermint proof-of-stake consensus mechanism.2 Injective values interoperability, enabling communication with other chains that employ the Inter-Blockchain Communication (IBC) protocol through Wormhole (a protocol developed through the Cosmos SDK).3 Injective is available as the native asset of the Injective blockchain, or as an ERC20 token. They are interconvertable via the Injective Hub, but the ERC20 token must be converted to native for staking. The current offering of INJ at Coinsquare is the ERC20 token only.

As with all assets, investing in Injective is not without some general risks. Many of these risks are identified and explained in our Risk Statement.

The relevant sections in the Risk Statement are as follows:  

Platform Risk, Short History Risk, Price Volatility, Potential Decrease in Global Demand for Digital Assets, Potential for Illiquid Markets, Transfers of Digital Assets are Irreversible, Concentration Risks, Uncertainty in Regulation, Financial Institutions May Refuse to Support Transactions Involving Digital Assets,  Digital Assets’ Blockchain May Temporarily or Permanently Fork and/or Split, Cyber-Security Risk, Airdrops, Issues with Cryptography Underlying Digital Asset Networks, Internet Risk, Open Loop System, Risk if Entity Gains a 51% Share of Digital Asset Network, Possible Increase in Transaction Fees, Possible Increase in Service Fees, Limited Canadian Investor Protection Fund Account, No Voting Rights, Custody of Digital Assets, Custody Risk Insurance, Threats to Coinsquare’s Physical Assets, Covid-19 Outbreak, Use of Leverage, Halting, Suspending, and Discontinuing Digital Assets.

In addition to the general risks, we outline some risks that are specific to Injective below. While we make an effort to identify every source of risk, we encourage you to do your own research and ensure you are comfortable investing in Injective.

INJ relation to the Cosmos Network

INJ relation to the Ethereum Network

INJ Burning

To be made available for trading on Coinsquare’s platform, a digital asset must pass the following due diligence reviews:

1. Coinsquare Securities Law Assessment
2. Coinsquare Digital Asset Security Audit
3. New Digital Asset Business Case

Coinsquare undertakes these three levels of due diligence in order to determine whether the digital asset is compliant with our legal and regulatory obligations, is secure, and has historical data supporting a beneficial business case. Coinsquare’s New Product Committee must provide final approval for a new digital asset to be made available on the platform.

1. References: 

    

   1. “Injective – About.” Injective. 2023. https://injective.com/about  
   1. Jemima Conlon. “What Is Injective (INJ)?” Ledger Academy. December 6, 2023. https://www.ledger.com/academy/what-is-injective  
   1. Wormhole. “Wormhole Gateway: A New Onramp to the Interchain.” Medium. August 7, 2023. https://blog.cosmos.network/wormhole-gateway-a-new-onramp-to-the-interchain-91fb2d3950fa  
   1. Coinmarketcap. “Injective (INJ) – About Injective.” 2023. https://coinmarketcap.com/currencies/injective/  
   1. Cosmos SDK. “CosmWasm Smart Contracts.” 2023. https://docs.cosmos.network/v0.46/CosmWasm/  
   1. Curious Cosmonaut Research. “Injective Whitepaper.” Medium. November 6, 2022. https://medium.com/@cosmonautcurious/injective-whitepaper-cdb95fa74c46  

    

   Other Useful Links: 

   Injective Twitter: https://twitter.com/Injective_